Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin

E. K. Rowinsky; M. R. Jiroutek; P. Bonomi; D. Johnson; S. D. Baker

Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin

E. K. Rowinsky
, M. R. Jiroutek
, P. Bonomi
, D. Johnson
, S. D. Baker

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Cancer Research
Volume	5
State	Published - Apr 1 1999

Disciplines

Pharmacy and Pharmaceutical Sciences

Cite this

@article{f968b33f9aae46ba825c02714c57a929,

title = "Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin",

author = "Rowinsky, \{E. K.\} and Jiroutek, \{M. R.\} and P. Bonomi and D. Johnson and Baker, \{S. D.\}",

year = "1999",

month = apr,

day = "1",

language = "American English",

volume = "5",

journal = "Clinical Cancer Research",

}

TY - JOUR

T1 - Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin

AU - Rowinsky, E. K.

AU - Jiroutek, M. R.

AU - Bonomi, P.

AU - Johnson, D.

AU - Baker, S. D.

PY - 1999/4/1

Y1 - 1999/4/1

UR - https://cufind.campbell.edu/pharmacy/1486

M3 - Article

VL - 5

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -

Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin

Disciplines

Other files and links

Cite this